Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe covid19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04978025
What this trial is testing

Colloidal Silver, Treatment of COVID-19

Who this might be right for
SARS (Severe Acute Respiratory Syndrome)
Hôpital Universitaire Sahloul 50
Large-scale testing (Phase 3)UnknownNCT04891172
What this trial is testing

Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients

Who this might be right for
Covid19
Dow University of Health Sciences 310
Not applicableStudy completedNCT06767241
What this trial is testing

Transcranial Non-invasive Electrical Stimulation of the Vagus Nerve in Hospitalized Moderate-to-severe COVID-19 Patients

Who this might be right for
COVID-19
University of Medicine and Pharmacy "Victor Babes" Timisoara 83
Not applicableStudy completedNCT05184166
What this trial is testing

Hospital Management and 1-year Outcome of Patients Aged 70 Years and Older With Severe COVID-19

Who this might be right for
COVID-19Elderly Patient
Centre Hospitalier le Mans 361
Not applicableLooking for participantsNCT06434701
What this trial is testing

Severe COVID-19 Infection in Children Presenting to EDs in Israel and England

Who this might be right for
COVID-19Inflammatory Response
Hadassah Medical Organization 500
Not applicableUnknownNCT04918901
What this trial is testing

Comparative Analysis of Clinical Parameters and Radiographic Changes of Severe COVID-19

Who this might be right for
Severe COVID-19
Second Affiliated Hospital, Zhejiang University, School of Medicine 80
Not applicableStudy completedNCT05196477
What this trial is testing

Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection

Who this might be right for
COVID-19
R-Pharm 3,087
Testing effectiveness (Phase 2)Ended earlyNCT04922957
What this trial is testing

A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)

Who this might be right for
Covid19
Enlivex Therapeutics Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT04596839
What this trial is testing

Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19)

Who this might be right for
Covid19
Dr. Md. Alimur Reza 60
Testing effectiveness (Phase 2)Study completedNCT05303376
What this trial is testing

Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness

Who this might be right for
COVID-19
Immune Biosolutions Inc 123
Not applicableStudy completedNCT04403932
What this trial is testing

Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Hospital San Carlos, Madrid 300
Testing effectiveness (Phase 2)Ended earlyNCT05156671
What this trial is testing

Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial

Who this might be right for
COVID-19
Universitätsklinikum Hamburg-Eppendorf 16
Not applicableUnknownNCT04768998
What this trial is testing

Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Goethe University 6,550
Testing effectiveness (Phase 2)Study completedNCT04515147
What this trial is testing

A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Who this might be right for
CoronavirusCovid19SARS-CoV-2+1 more
CureVac 668
Testing effectiveness (Phase 2)Study completedNCT04635943
What this trial is testing

Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19

Who this might be right for
Covid19Coronavirus InfectionSARS-CoV Infection
Universidad Peruana Cayetano Heredia 186
Early research (Phase 1)Study completedNCT04851821
What this trial is testing

The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)

Who this might be right for
a Randomized Double-blind StudySevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)PHYTOTHERAPIE
Hôpital Universitaire Sahloul 80
Not applicableStudy completedNCT04503447
What this trial is testing

COVID-19 Seroprevalence Study in ITM Staff

Who this might be right for
Covid19
Institute of Tropical Medicine, Belgium 330
Not applicableStudy completedNCT04623138
What this trial is testing

A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections

Who this might be right for
Covid19SARS-CoV Infection
Evidation Health 847
Large-scale testing (Phase 3)Ended earlyNCT04492358
What this trial is testing

Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center

Who this might be right for
Covid19
Maria Joyera Rodríguez 54
Testing effectiveness (Phase 2)Study completedNCT04659109
What this trial is testing

Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19

Who this might be right for
SARS-CoV InfectionAcute Respiratory Distress SyndromeCOVID-19+1 more
Acticor Biotech 60
Next Page